Category: Business

Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers

Mumbai (Maharashtra) [India], March 7: Thermo Fisher Scientific introduced its latest generation of SeqStudio Flex Series Genetic Analyzer to enable customers’ cutting-edge research in areas such as gene editing and infectious disease. Capillary Electrophoresis (CE), which enables Sanger sequencing and fragment analysis is an important tool for improving clinical research and advancing scientific discovery.  The SeqStudio Flex Genetic Analyzer delivers the gold-standard quality of CE technology with accurate data and reliable performance.

“At Thermo Fisher we strive to provide innovative and advanced products that meet the needs of our customers. The SeqStudio Flex Series Genetic Analyzers are designed keeping our customers in mind, offering a simplified, more efficient workflow, multiple applications and an exceptional level of accuracy to advance their research. The introduction of the product reaffirms our commitment to Innovation and our investments in CE technology expands our portfolio with the latest generation of innovative, mid-throughput genetic analyzers,” said Amit Chopra, managing director, India, and South Asia, Thermo Fisher Scientific. 

The new mid-throughput genetic analyzer introduces design and technological advancements for enhanced flexibility, usability and connectivity. The instrument has increased plate capacity and may be loaded at any time without cancelling or waiting for a run to complete, improving sample throughput and walk-away capacity and scheduling flexibility.

“With the increased plate capacity supported by design enhancements and simplified workflow, SeqStudio Flex Series Genetic Analyzers are highly capable of accelerating genomic research,” added Kapil Sood, senior director, life sciences solutions, Thermo Fisher Scientific.

The intuitive and flexible system comprising advanced Wi-Fi connectivity empowers remote plate set up and remote monitoring as well as facilitate streamlined data transfer, analysis, and scientific collaboration. The SeqStudio Flex Series Genetic Analyzer is the first CE-based instrument with remote servicing capabilities for faster issue resolution.

To learn more about the Applied Biosystems SeqStudio Flex Series Genetic Analyzers, visit thermofisher.com/seqstudioflex

*For research use only. Not for use in diagnostic procedures.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

New Delhi (India), March 7: Until a while ago, it was a known stereotype that women were incapable of running a successful business. That they should focus on taking care of the family, children and home while the man earns and runs the household. Women were perceived as emotional and incapable of entering the harsh business world.

However, every woman defies this preconception and prejudice in today’s world. Several women have taken steps in this direction by entering the business field. Starting from the ground up, learning everything, planning and re-planning and persevering even in the face of adversity.

The Vocal for Local app has successfully helped thousands of women revolutionise and scale their businesses. Change, opportunities, reinvention, and convenience are all part of Vocal For Local. Unlike any other, it’s a mobile app that acts as a marketplace for thousands of home business owners to sell their products. Their objective is to build a user-friendly platform for home entrepreneurs to promote their talents and brands to a larger audience. They want to make the entire discovery process from discovery to delivery as simple as possible. It’s the easiest thing to do by simply downloading the app from your App Store or Google Playstore!

https://play.google.com/store/apps/details?id=io.vocal.vfl

Women empowerment has always been a priority for Vocal For Local’s founders, Mihir Turakhia and Chaitanya Davda. Vocal For Local supports small businesses and home entrepreneurs. The app has evolved into a valuable resource for women who want to establish a home business without any hassle. It has three areas of expertise: food, beauty, and handicrafts. It’s a free app that allows women from any strata of society to get started without worrying about paying a registration fee.

Various small businesses have successfully achieved a wider audience with this app. Even consumers who enjoy unique and homemade products have a single location to browse. It’s a one-of-a-kind network for home entrepreneurs that’s kept small businesses afloat, even amid the pandemic.

There is a 94-year-old woman who created her own business and sells with Vocal For Local! Some ladies began during the lockdown and received their first customers practically immediately with the help of the app.

Another business owner sells ice cream cone waffles, savoury waffles, and sandwiches on the platform. She claims that Vocal For Local has immensely benefited her in reaching a wider audience with her products as a home entrepreneur.

After discovering the ‘Sindhi Potli’ pickle, a young entrepreneur discovered her calling. Despite the pandemic, she decided to start her own home business.

Another fun one we found was a ‘saas-bahu’ duo who sells home-cooked meals! Many people have been inspired by their journey. They were able to shatter the myth that mothers-in-law and daughters-in-law can’t get along!

You’ll come across several entrepreneurs selling handmade skincare, haircare, and even cosmetics! It’s encouraged entrepreneurs of all ages, from young adults to elderly grandmothers to express and showcase their talents on the app. Vocal For Local has evolved as a platform, a community, and a family. They’ve assisted thousands of women in achieving their goals and encouraged them to keep going.

This Women’s Day, let’s celebrate the day’s true meaning. Gift the women in your life independence and let them be part of a platform dedicated to helping India grow. One home at a time. That’s why HOME Hongey Kaamyaab!

March 7: Sambhav, India’s first legal helpline for women at work, is an initiative by a group of young lawyers, who are launching this through a dedicated phone number and whatsapp number (9689-9689-10).

Are you a woman business owner, woman who wants to start her own business, or a woman professional with legal issues at work? Then Sambhav’s helpline is for you. You can call or Whatsapp this number from anywhere in India for the legal advice related to work that you require.

For more information, visit our Sambhav page!

Lawyers are volunteering their time to give free legal advice to working women!

Lawfarm.in, India’s premier portal for legal services, is proud to be the online partner for this initiative.

The mission behind this is to make it ‘Sambhav’ or ‘Possible’ for women to be financially independent, by taking care of all the legal issues that they may face.

Sambhav’s helpline will provide free legal advice to related to issues such as business registrations and licenses, GST or other compliances, brand protection through intellectual property (patent, trademark, copyright, design), contracts, money recovery, disputes, business property, employment related issues, cyber-crimes, etc.

After the initial legal advice, which will be provided by lawyer volunteers free of cost, Sambhav might refer the work to Lawfarm for which we will provide a flat 30% discount to women for legal services. We will run this discount for the whole month of March!

Lawfarm.in is looking to help many women business owners that face legal issues and also many women who are looking to start their home-based businesses, but don’t know the legalities behind it such as licenses for food business, e-commerce business, etc.

Lawfarm Team says: “When we think of legal help for women, we normally think of domestic violence or matrimonial issues, but what about women who are working hard to become financially independent? That is the best form of women empowerment and that’s why we are excited to support this wonderful initiative – Sambhav – by providing women with affordable business-legal services.”

The discounted legal services will be provided by Lawfarm.in for the whole of March. Want to know more? Come to Sambhav today!

Kolkata (West Bengal) [India], March 7:  Cool Caps Industries Limited (Cool Caps) is engaged in the business of manufacturing a wide range of plastic bottle caps and closures, proposes to open its initial public offer (IPO) of 30,60,000 Equity Shares of Rs.10 each under book building process aggregating to Rs. 1,162.80 Lakh. Price Band shall be announced soon; the Issue is proposed to be list on the NSE Emerge platform. The issue will open on 10th March, 2022 and will close on 15th March 2022.

The net proceeds from the IPO will be utilized to meet working capital requirements and for general corporate purposes.

The Lead Manager to the Issue is Holani Consultants Private Limited and The Registrar to the Issue is Link In time India Private Limited.

Cool Caps, founded in 2015, company is manufacturing bottle caps and closures which include soda bottle caps, soft drink bottle caps, mineral water bottle caps, juice bottle caps and closures as per client specifications from units situated in Howrah in West Bengal and Kotdwar in Uttarakhand.

The company is Promoted by Purv Flexipack Private Limited, Mr. Rajeev Goenka and Mr. Vanshay Goenka. They belong to Goenka family of Sindharam Sawarmal, Dry Fruits, a well- known entity of Kolkata. 

The company has established strong clients like Bisleri, Kingfisher, IRCTC, Patanjali, Clear, etc to supply plastic bottle caps.

The company also into manufacturing N95 Face Masks from its unit situated in Howrah, West Bengal to help the community during the COVID-19 pandemic. It is also involved in the manufacturing of shrink films through its subsidiary Purv Ecoplast Pvt Ltd. and trading of plastic granules to provide one-stop packaging solutions to its customers.

The Company has its offices located in Kolkata, West Bengal. The consolidated Sales of the Company for the year ended on March 31, 2021 stood at Rs. 3,129.84 lakh, The Company’s consolidated Profit after tax for the year ended on March 31, 2021 stood at Rs. 291.72 lakh.  For the last 3 financial years, FY19 – FY21 company’s Revenue has grown at a CAGR of 27.68 while EBITDA & PAT have grown at a CAGR of 46.19% & 45.99% respectively.

Mr. Rajeev Goenka, Promoter, Chairman and Managing Director, Cool Caps said, “We are in the sunrise industry as consumption and demand for the safe and branded Food and Beverages products are increasing. Every bottled product requires caps and closures so opportunities in the markets are numerous. With our long-term relations with our clients and our capability we are in a very good position to capture the growth opportunity.”

Mr. Ashok Holani, Director, Holani Consultants Private Limited, BRLM to the issue highlighting the Issue and investment rationale said “Cool Caps is one of the leading players in the plastic caps and closure industry with commendable market share and the company is having a continuous track record for the profits. The issue is also fairly priced at the Pre issue P/E multiple of 11.07 on FY21 EPS of Rs.3.43 per share.”

March 7: MetaSpace has officially announced the public launch of its simulated metaverse platform. The life-like digital avatars of each individual will soon be able to have a whole experience of a highly immersive and shared virtual environment where they will literally be able to explore, earn, live, travel, and trade NFTs in a way similar to the real world and beyond.

“After many months and days of hard work and dedication from our team, we are more than happy to announce the commencement of MetaSpace,” said Mo Akram, Founder of MetaSpace. “Throughout this journey, our primary goal has been to create a more valuable, user-centric, and highly anticipated explore-to-earn metaverse that will help transform the future of mankind,” he added.

MetaSpace, at its heart, is an open-world metaverse giving you the direct opportunity to build community and maximize your monetization potential through exploration, playing games, and more. In order to create a blockchain-driven massively multi-user virtual world, MetaSpace has been built on Polygon, a layer-2 blockchain protocol that had the power to make its ambitions bring to life.

However, the metaverse they are developing includes multiple functionalities like gaming, entertainment, shopping, etc. All of which can be done virtually. The experience here is profound, multifaceted, and enriching – that’s what MetaSpace is pushing for with its own ecosystem.

They are encouraging each one of you to play and earn by providing highly potent benefits from an AAA game centered on an infinity space lifestyle incorporating play-to-earn attributes, trading of in-metaverse assets present in the form of NFTs, space travel, and more. Moreover, the hyper-real alternative world of MetaSpace allows one to visit holy places, shop from the stores of big brands, and a virtual arena where one would be able to challenge and fight their mates – all while confined to homes.

Apart from this, MetaSpace is also adding new innovations for a feature-rich ecosystem by hosting virtual concerts of celebrities from across the globe as well as stand-up comedy shows for you to closely interact with your idol, relish, dance, and laugh.

To escape reality and soar over the world of possibilities, join the MetaSpace community:

Telegram Channel | Twitter

New Delhi (India), March 5: Recovering unclaimed shares, IEPF claims, share regularization, name deletion of duplicate share certificates is not a daunting task anymore and there is no need to address heaps of legal implications either. Thanks to Infiny Solutions, India’s leading IEPF recovery company Infiny Solution is helping investors in reclaiming their lawful assets most expediently.

Infiny Solutions has established itself as the most trusted Investor Education and Protection Fund Authority (IEPF) recovery company in the country. The IEPF Authority was established by the Government of India under the provisions of section 125 of the Companies act, 2013 to make refunds of shares, unclaimed dividends, matured deposits/debentures etc. to investors and to promote awareness among investors on September 7, 2016.

“Our experienced team professionals advise the clients who are not aware of their investments in shares due to the demise of the prime investors. In such a situation, our professionals get in touch with the nominees and help them get their due capital back in the most expedient manner possible” said a company spokesperson.

Giving a case study, the company spokesperson said they helped recover unclaimed shares for the Bhatiya family. The patriarch of the Bhatiya family died many years ago and the family was unaware of his investment ventures. The experienced team at Infiny Solutions helped them get a duplicate share certificate and the unclaimed shares were recovered.

Similarly, one Rajkumari Sharma, who lost her husband many years ago, was helped in recovering unclaimed shares through the IEPF claim process. Sharma received a handsome amount to help her nurture her children in a better environment.

Infiny Solutions

info@infinysolutions.com

https://infinysolutions.com/

Enhances both innate & adaptive immunity and strengthens body’s immune response to viral infections

March 5: In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its antiviral drug VIRALEX® by the Drug Controller General of India (DCGI). As per the results of a double-blind randomized controlled trials (RCT), the drug helps in early relief of the clinical symptoms in mild tomoderateCOVID-19 patients.

Viralex® has been found to be effective and well tolerated in mild to moderate COVID-19, in two Randomized Controlled Clinical Trials conducted on 499 Indian patients.

In line with the DCGI’s current approach for approval of medicines for the management of the ongoing pandemic, approval for VIRALEX® (Generic name: Inosinepranobex) is based on the results of the robust phase 2 and phase 3RCTs conducted in India, and the well-established safety profile of the drug.

As per the results of the Phase 3 Randomized, Double-blind, Placebo-controlled Trial, 80.17% of patients treated with VIRALEX® showed clinical improvement on day 6, which is significantly higher (p<0.001) from that in the controlled group.

(52.38%) among the mild to moderate non-hospitalized COVID-19 patients. Clinical Cure was also significantly higher in the VIRALEX® group as compared to that in the placebo group on day 6 of treatment. There was early improvement and cure from symptoms in patients who received VIRALEX®. This drug was well tolerated by the patients without any serious side effects. The study was conducted during the Delta wave of the pandemic.

Randomized, Double-Blind, Placebo-controlled, Multicentre Trial is considered as the clinical research methodology of the highest global standard for evaluating drugs against diseases. Themis is one of the few companies to submit data from a higher number of patients from RCTs for approval in management of COVID-19.

After detailed deliberation, the drug regulatory authority granted permission to manufacture and market this new drug for restricted emergency use of the drug as an add on therapy for treatment of mild and moderate COVID-19.

VIRALEX® would be available on the prescription.

Based on the promising study results, the drug appears to offer immense clinical benefit to the patients in the early stages of COVID-19, thus reducing the load on the healthcare system.

VIRALEX® is an immune modulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body’s defence response to viral infections. In an invitro study initiated by Themis, it showed dose-dependent inhibition of viral replication against SARS-CoV-2 (COVID-19).

According to Themis, VIRALEX® will be manufactured at an EU-GMP-certified facility with the highest safety standards and stringent manufacturing protocols in place, and the medication will be available in the form of a 500 mg tablet at a much affordable price.

Speaking at the release, Dr. Sachin Patel, Managing Director & CEO of Themis Medicare Ltd. said, “Our endeavor has always been to develop medicines that benefit patients and make healthcare far, far more effective. Given the current scenario of grave health concerns and economic challenges surrounding COVID-19 in India, this is our effort to contribute to the well being of people of India”.

“Due to the frequently mutating trend of the virus, the uncertainties of the pandemic continue. We hope access to effective treatment such as VIRALEX® will offer a much-needed therapeutic solution, and if initiated early in the disease, it would reduce the load on the healthcare system.”

Commenting on the significance of this development, Dr. Ashok Swain, Head Clinical Development, congratulated the entire Themis Medicare Ltd. team for achieving an important milestone of adding this effective medicine with an established safety profile to address the unmet need in the management of the pandemic.

“VIRALEX® is a new ray of hope in these challenging times,” he said.

Dr Raja Dhar, eminent pulmonologist and Director and Head of Department of Pulmonology, C K Birla Hospitals, said “Inosine Pranobexisa drug which enhances host immunity (immune modulatory effect) and can affect viral RNA and hence inhibits growth of several viruses. Phase 3 Double blind RCTs are rarein COVID 19. I am heartened to hear that Themis Medicare has come up with such a trial, which shows early clinical response and shortened period of recovery when used in mild to moderate COVID19 cases. This drug, if successfully used in clinical practice would considerably reduce the burden on healthcare system.

Dr Dhar is also the current Chair of Training and Education Initiatives, Indian Chest Society, and Director of Research and Training, National Allergy Asthma Bronchitis Institute.

With a strong R&D backup, skilled domestic & export teams, and 4 state-of-the-art manufacturing sites, the endeavour at Themis has always been to support the medical fraternity with solutions for major unmet medical needs like VIRALEX® for COVID-19…and still counting!

About Themis Medicare Ltd

Themis Medicare was incorporated in 1969 as a joint venture partnership at Vapi. Today, it is one of the fastest growing pharma Company specializing in the development of complex molecules. With strong research focus on injectables, complex generic products and drug-delivery systems, the Company has evolved in to being a formidable layer in the complex generics space.

It has a diversified business model with presence across the B2B model and strong presence in domestic B2C market. The Company also has a significant export presence in the RoW geographies. The qualified and experienced Management team is complemented by highly skilled R&D workforce. The Company has three vertically integrated manufacturing facilities, of which two are focused on developing APIs–1 each involved in manufacturing Synthetic API and Fermentation based API, and 1 is involved in manufacturing of Finished Dosage Formulations. Themis offers products in various dosage forms in multiple therapeutics areas with leadership in Pain Management and Critical Care. The Company has a strategy to focus and grow its injectables portfolio and develop its NDDS presence.

For more details, please visit: www.themismedicare.com

New Delhi (India), March 5: UK-based global data analytics and ERP specialist consultancy company Kagool expanded its footprint in Hyderabad by inaugurating a new development centre in the city’s Financial District on Saturday. Jayesh Ranjan, Principal Secretary of IT Ministry, Telangana, inaugurated the centre.

“The new office space marks the roll-out of the company’s aggressive India growth plan. We are looking to increase our India headcount to 2000 by end of 2025” said, Kalyan Gupta Brahmandlapally, Head of India, Kagool Data Private Ltd.

“Kagool’s partnerships with Microsoft and SAP and our twin data modernisation accelerator products Velocity and Pulse are fuelling the company’s growth in supporting global clients modernise their ERP, Analytics and Integration landscapes. Going forward, we are targeting utilities, manufacturing, retail and public sector companies for business opportunities,” Kalyan Gupta said.

Daniel James Barlow, Group CEO of Kagool, who joined the inauguration online from the company’s UK headquarters, said, “Our customers are seeing the value and agility that modern cloud technologies can bring to their global enterprises and are seeing Kagool as the right delivery partner to achieve business value quickly and predictably.  Our India operations are key to our current operations and overall strategy, helping us to continue to grow our business 100% year on year.  The enormous talent base and dedicated, enthusiastic workforce are why we continue to invest heavily in our India operations.”

Barlow also said Kagool plans to expand its footprint in the USA, Mexico, Middle East and Europe in the next year.

Speaking after inaugurating Kagool’s new development centre, Jayesh Ranjan, IAS, Principal Secretary for IT, Govt. of Telangana said, “Congratulations to Team Kagool for opening their new development centre, their second office in Hyderabad. I feel very proud of the achievements of the company. Hyderabad, at one point in time, was perceived largely as a services centre. But now it is quite encouraging to find companies in the product development space. It is nice to hear that Kagool in partnership with Microsoft has developed Velocity, which is one of the most used products, particularly when it comes to adoption to SAP, Data Migration etc. We all feel very proud about this because our whole attempt at the Government also is to give a new dimension to the Hyderabad IT industry. We want more and more product development, more and more innovation to happen. And eventually, this is where the trend is the future is going to be of those people who develop more user-friendly products, enterprise-ready products and solutions using emerging technology. I guess this is where Kagool is also getting.”

Complimenting Kagool, HYSEA president Bharani K Aroll appreciated the company’s commitment to Telangana. “Kagool helped drive technology-led growth by investing in talented youth of the state and building long-term partnerships with various state institutions creating more employment opportunities,” he said.

Kagool is a UK Based Product and Service based Software Company. Headquartered in the UK since 2004. The company is a leading global data & analytics and ERP specialist, offering consultancy and best of breed integration solutions. Kagool delivers real results to global business organizations, ensuring a high level of quality and customer engagement is maintained every time. We leverage our industry knowledge and leadership in technology, solution development and integration to align our partner’s innovations with specific business needs. Kagool started more than 15 years ago as a data & analytics solution provider, progressively expanded into five different offices globally and undoubtedly, Hyderabad has become home to the largest conglomeration of employees in India for The Group!

March 5: Women empowerment is one of the hot topics for discussion in India and the context is always aligned with external support for women. Changing this perception, ‘The Atypical Tale of a Typical Indian Woman’ by Kanika Saxena is a book based on Women’s Empowerment with a different perspective. It focuses on empowering the woman from within so that she can take on tough situations.

Entrepreneur and author, Kanika Saxena is the Founder & CEO of ‘The Writing Right’, a content writing startup, and has published six books in the self-help genre. The book, The Atypical Tale of a Typical Indian Woman starts with the different stages in the life of a woman like a daughter, wife, mother, etc., and the challenges they face at each stage and ways to overcome them. The author focuses on the demands of the family and society by a woman. She explains how women are important members of society who can be change-makers. According to her, the role of the mother is vital because she brings children into the world and raises the future citizens of society. So, a mother has a strong influence on how these citizens shape up.

According to Kanika, a mother needs to lead by example as she is the role model for both her son and daughter. Mothers need to treat themselves with respect and not be subservient to the male members of the family. If she treats everyone equally without undermining herself, the daughter will grow up with the belief that men and women are equal. And, the son will learn how to treat women with respect. This change can come about only at home and impact society.

The foundation for women’s empowerment begins at home. It depends on how the parents welcome a girl child and treat her. The daughter is empowered when parents treat sons and daughters equally and give daughters the freedom to make choices. When a family raises a daughter without bias they will be more confident. And they can take many responsibilities and use the external resources for empowerment.

Kanika Saxena says that for a mother to have a balanced approach in how she treats herself and her family members, she needs to empower herself. Self-empowerment begins with self-acceptance and self-care. She emphasizes that only when a woman takes care of herself, she can take care of others around her.

All the suggestions and ideology presented in the book come from Kanika’s personal experience and that of other women. The book is based on real-life stories of real women and what they go through in their lives. The solutions suggested have been tried and tested by the author, and other women who have broken the stereotype.

Empowering herself through her journey, Kanika holds degrees in engineering and management. She has worked for some of the top organizations in India for seven years and chose to be a stay-at-home mother for her kids. After being on sabbatical for twenty years she re-entered the corporate world as a fresher in content writing in 2016, started as a freelancer and soon founded her content writing startup ‘The Writing Right in 2020’. Kanika embarked on her journey as an author at the same time and published six books in 18 months. Her journey was not an easy one, she has taken care of her responsibilities for her family without neglecting herself.  Kanika shares her recipe for success with The Atypical Tale of a Typical Indian Woman!

Royale Estate Group to foray into the development of a state-of-the-art Industrial Park

 Chandigarh (India), March 5: After carving a niche for itself in the region’s affordable, ethical and quality housing sector, Royale Estate Group (REG) has become a partner to ensure holistic economic development of the region. It is creating a state-of-the-art Integrated Industrial Park, the vision document cum blueprint of which has been made in consultation with industry experts.

“Our decision to foray into the Industrial sector is like giving back to society. Housing segment is more lucrative for the real estate players but not to us beyond a point. At REG, we wish to give back to society in a different and sustainable way. Our initiative for the industries will be a case in point, which will further improve the ease of doing business and generate employment opportunities,” said Piyush Kansal, a young Director at REG.

The industrial park, which will be of an international level will be established soon.

“There is a need to retain the migration of talent and capital from the region. This will be possible only when we create quality infrastructure for local, domestic and foreign investors. It is an important task we have undertaken after realizing the fact that as a responsible, transparent and honest real estate player, we also have to become a partner in the economic development of the region,” said Neeraj Kansal, Director, REG.

It is worth mentioning that REG built housing complexes have become a favourite for the region’s homebuyers as they do not compromise with fair practices. “It is true that buyers should take precautions while investing their money in real estate. Builders and promoters also have to be accountable to them. They cannot renege on promises of timely delivery of residential and commercial units to investors,” added Piyush Kansal.

“We provide a safe investment option as we do not take any kind of bank or private loan, and create the projects on 100 per cent registered land. An approved project should stick to ethical norms set by the RERA and the state government. The layout plan must be approved by the government bodies in totality,” added Neeraj Kansal.

REG has developed 17 million plus square feet area in 20 plus projects over the last many years. 10,000 properties have been delivered so far and there are 10 plus ongoing projects. “Our major strength lies in the fact that first we purchase land, followed by approvals. We don’t leave our customers after the sale. Rather we support them to get acquainted with the property and surroundings and provide them with assistance because we have an in-house post sale assistance team available all the time. There is due diligence in our approach,” said Ashish Mittal, another Director of the group.

The upcoming Industrial park at the Banur Tepla Road (BTR) is slated to turn fortunes of the region and will make Chandigarh region and Punjab an economic engine of north India. The reason: all types of industries be they large, MSME, start-ups etc will come up because of the global level infrastructure being planned. The best part is that the group behind the Integrated Industrial park has a legacy of providing safety and security of investments and has earned a sobriquet of being ‘Honest Builders.’ The development of an industrial park will be a boon for the region’s holistic economic development and will create job opportunities.